Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131884 · ClinicalTrials.gov registry record · NA
Pilot Study of Fosamax in Spinal Cord Injury
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01131884 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 1 participants.
The verdict
NCT01131884, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Study is designed to evaluate the efficacy of oral fosamax in prevention on osteoporosis in acute spinal cord injury. Efficacy will be measured by a duel energy X-Ray absorptiometry (DEXA) scan every 6 months. Patients will complete 3 visits, screening, 6 months, 12 months and be required to take oral fosamax versus placebo weekly.
Interventions
- DRUG Placebo
- DRUG Fosamax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01131884
The ClinicalTrials.gov registry entry for NCT01131884 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01131884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01131884 about?
NCT01131884 is a clinical study titled "Pilot Study of Fosamax in Spinal Cord Injury". Study is designed to evaluate the efficacy of oral fosamax in prevention on osteoporosis in acute spinal cord injury. Efficacy will be measured by a duel energy X-Ray absorptiometry (DEXA) scan every 6 months. Patients will complete 3 visits, screening, 6 months, 12 months and be required to take or...
What is the current status of trial NCT01131884?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2010-06. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01131884?
The interventions under investigation include: Placebo (DRUG), Fosamax (DRUG).
Who is sponsoring clinical trial NCT01131884?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.